- Apr 2, 2009
- 5,171
- 13,288
- 67
Electronic Cigarettes' Nicotine Vapor Stokes U.S. Agency, May Torch Sales
Electronic Cigarettes' Nicotine Vapor Stokes U.S. Agency, May Torch Sales - Bloomberg
Bloomberg reporter Molly Peterson attended last week's FDA workshop on longterm nicotine use, where my comments criticizing FDA Deputy Commissioner Josh Sharfstein for misrepresenating the evidence about e-cigarettes and for trying to ban e-cigarettes prompted her to write this article.
Neither ALA's Paul Billings (who I've collaborated with for 20 years on other federal tobacco legislative issues) nor FDA's Siobhan DeLancey attended that conference, nor have either responded to many dozens of e-mails I've sent them on e-cigarettes, including all of the scientific studies and virtually all laboratory tests on e-cigarettes.
Meanwhile, GSK's Howard Marsh spoke at last week's FDA conference urging the FDA to allow GSK to market its nicotine products for long term use. But of course, Marsh knows that NRT cannot effectively compete against far more effective cigarette alternatives like e-cigarettes or smokeless tobacco products, so he wants the FDA to ban e-cigarettes and lobbied for the FSPTCA to confuse people that smokeless tobacco is as hazardous as cigarettes.
Electronic Cigarettes' Nicotine Vapor Stokes U.S. Agency, May Torch Sales - Bloomberg
Bloomberg reporter Molly Peterson attended last week's FDA workshop on longterm nicotine use, where my comments criticizing FDA Deputy Commissioner Josh Sharfstein for misrepresenating the evidence about e-cigarettes and for trying to ban e-cigarettes prompted her to write this article.
Neither ALA's Paul Billings (who I've collaborated with for 20 years on other federal tobacco legislative issues) nor FDA's Siobhan DeLancey attended that conference, nor have either responded to many dozens of e-mails I've sent them on e-cigarettes, including all of the scientific studies and virtually all laboratory tests on e-cigarettes.
Meanwhile, GSK's Howard Marsh spoke at last week's FDA conference urging the FDA to allow GSK to market its nicotine products for long term use. But of course, Marsh knows that NRT cannot effectively compete against far more effective cigarette alternatives like e-cigarettes or smokeless tobacco products, so he wants the FDA to ban e-cigarettes and lobbied for the FSPTCA to confuse people that smokeless tobacco is as hazardous as cigarettes.